Abstract
Rationale
Animal models aimed to mimic mania have in common the lack of genuine affective parameters. Although rodent amphetamine-induced hyperlocomotion is a frequently used behavioral model of mania, locomotor activity is a rather unspecific target for developing new pharmacological therapies, and does not necessarily constitute a cardinal symptom in bipolar disorder (BD). Hence, alternative behavioral markers sensitive to stimulants are required.
Objectives
Since d-amphetamine induces appetitive 50-kHz ultrasonic vocalizations (USV) in rats, we asked whether established or potential antimanic drugs would inhibit this effect, thereby possibly complementing traditional analysis of locomotor activity.
Methods
Amphetamine-treated rats (2.5 mg/kg) were systemically administered with the antimanic drugs lithium (100 mg/kg) and tamoxifen (1 mg/kg). Since protein kinase C (PKC) activity has been implicated in the pathophysiology of bipolar disorder and the biochemical effects of mood stabilizers, the new PKC inhibitor myricitrin (10, 30 mg/kg) was also evaluated.
Results
We demonstrate for the first time that drugs with known or potential antimanic activity were effective in reversing amphetamine-induced appetitive 50-kHz calls. Treatments particularly normalized amphetamine-induced increases of frequency-modulated calls, a subtype presumably indicative of positive affect in the rat.
Conclusions
Our findings suggest that amphetamine-induced 50-kHz calls might constitute a marker for communicating affect that provides a useful model of exaggerated euphoric mood and pressured speech. The antimanic-like effects of the PKC inhibitors tamoxifen and myricitrin support the predictive and etiological validity of both drugs in this model and highlight the role of PKC signaling as a promising target to treat mania and psychosis-related disorders.
Similar content being viewed by others
References
Ahrens AM, Ma ST, Maier EY, Duvauchelle CL, Schallert T (2009) Repeated intravenous amphetamine exposure: rapid and persistent sensitization of 50-kHz ultrasonic trill calls in rats. Behav Brain Res 197:205–209
Amir E, Seruga B, Niraula S, Carlsson L, Ocaña A (2011) Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst 103:1299–1309
Belmaker RH (2004) Bipolar disorder. N Engl J Med 351:476–486
Browman KE, Kantor L, Richardson S, Badiani A, Robinson TE, Gnegy ME (1998) Injection of the protein kinase C inhibitor Ro31-8220 into the nucleus accumbens attenuates the acute response to amphetamine: tissue and behavioral studies. Brain Res 814:112–119
Brudzynski SM (2005) Principles of rat communication: quantitative parameters of ultrasonic calls in rats. Behav Genet 35:85–92
Burgdorf J, Knutson B, Panksepp J (2000) Anticipation of rewarding electrical brain stimulation evokes ultrasonic vocalization in rats. Behav Neurosci 114:320–327
Burgdorf J, Knutson B, Panksepp J, Ikemoto S (2001) Nucleus accumbens amphetamine microinjections unconditionally elicit 50 kHz ultrasonic vocalizations in rats. Behav Neurosci 115:940–944
Burgdorf J, Kroes RA, Moskal JR, Pfaus JG, Brudzynski SM, Panksepp J (2008) Ultrasonic vocalizations of rats (Rattus norvegicus) during mating, play, and aggression: behavioral concomitants, relationship to reward, and self-administration of playback. J Comp Psychol 122:357–367
Ciucci MR, Ma ST, Fox C, Kane JR, Ramig L, Schallert T (2007) Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol. Behav Brain Res 182:284–289
Ciucci MR, Ahrens AM, Ma ST, Kane J, Cormack L, Schallert T (2009) Reduction of dopamine synaptic activity: degradation of 50-kHz ultrasonic vocalization in rats. Behav Neurosci 123:328–336
Cowell RM, Kantor L, Hewlett GH, Frey KA, Gnegy ME (2000) Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. Eur J Pharmacol 389:59–65
Einat H, Yuan P, Szabo ST, Dogra S, Manji HK (2007) Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: Implications for the development of novel therapeutics for bipolar disorder. Neuropsychobiology 55:123–131
Friedman JN, Hurley RA, Taber KH (2006) Bipolar disorder: imaging state vs. trait. J Neuropsychiatry Clin Neurosci 18:296–301
Giambalvo CT (1992) Protein kinase C and dopamine transport – 1. Effects of amphetamine in vivo. Neuropharmacology 31:1201–1210
Gitlin M (2006) Treatment-resistant bipolar disorder. Mol Psychiatry 11:227–240
Gould TD, O'Donnell KC, Picchini AM, Manji HK (2007) Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology 32:1321–1333
Grønli JT, Murison R, Fiske E, Bjorvatn B, Sørensen E, Portas CM et al (2005) Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions. Physiol Behav 84:571–577
Hahn CG, Umapathy HY, Wang R, Koneru DF, Friedman LE (2005) Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. J Psychiatr Res 39:355–363
Harrison-Read PE (2009) Models of mania and antimanic drug actions: progressing the endophenotype approach. J Psychopharmacol (Oxf) 23:334–337
Kantor L, Gnegy ME (1998) Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J Pharmacol Exp Ther 284:592–598
Kantor L, Hewlett GH, Park YH, Richardson-Burns SM, Mellon MJ, Gnegy ME (2001) Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells. J Pharmacol Exp Ther 297:1016–1024
Manji HK, Lenox RH (1999) Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 46:1328–1351
Meotti FC, Luiz AP, Pizzollati MG, Kassuya CAL, Calixto JB, Santos ARS (2006) Analysis of the antinociceptive effect of the flavonoid myricitrin: evidence for a role of the l-arginine-nitric oxide and protein kinase C pathways. J Pharmacol Exp Ther 316:789–796
Natusch C, Schwarting RKW (2010) Using bedding in a test environment critically affects 50-kHz ultrasonic vocalizations in laboratory rats. Pharmacol Biochem Behav 96:251–259
Nierenberg AA (2010) A critical appraisal of treatments for bipolar disorder. Prim Care Companion J Clin Psychiatry 12:23–29
Pereira M, Siba IP, Chioca LR, Pizzolatti MG, Correia D, Vital MABF et al (2011) Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models. Prog Neuropsychopharmacol Biol Psych 35:1636–1644
Sabioni P, Baretta IP, Ninomiya EM, Gustafson L, Rodrigues ALS, Andreatini R (2008) The antimanic-like effect of tamoxifen: behavioural comparison with other PKC-inhibiting and antiestrogenic drugs. Prog Neuropsychopharmacol Biol Psych 32:1927–1931
Scattoni ML, Crawley J, Ricceri L (2009) Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci Biobehav Rev 33:508–515
Schwarting RKW, Jegan N, Wöhr M (2007) Situational factors, conditions and individual variables which can determine ultrasonic vocalizations in male adult Wistar rats. Behav Brain Res 182:208–222
Smith R, Daves JM (1977) Comparative effect of d-amphetamine, l-amphetamine and methylphenidate on mood in man. Psychopharmacology (Berl) 53:1–12
Song C, Leonard BE (2005) The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29:627–647
Steketee JD (1993) Injection of the protein kinase inhibitor H7 into the A10 dopamine region blocks the acute responses to cocaine: behavioral and in vivo microdialysis studies. Neuropharmacology 32:1289–1297
Thompson B, Leonard KC, Brudzynski SM (2006) Amphetamine-induced 50 kHz calls from rat nucleus accumbens: a quantitative mapping study and acoustic analysis. Behav Brain Res 168:64–73
Van Kammen DP, Murphy DL (1975) Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44:215–224
Williams SN, Undieh AS (2010) Brain-derived neurotrophic factor signaling modulates cocaine induction of reward-associated ultrasonic vocalization in rats. J Pharmacol Exp Ther 332:463–468
Willson MC, Bell EC, Dave S, Asghar SJ, McGrath BM, Silverstone PH (2005) Valproate attenuates dextroamphetamine-induced subjective changes more than lithium. Eur Neuropsychopharmacol 15:633–639
Wöhr M, Schwarting RKW (2007) Ultrasonic communication in rats: can playback of 50-kHz calls induce approach behavior? PLoS ONE 2:e1365
Wöhr M, Houx B, Schwarting RKW, Spruijt B (2008) Effects of experience and context on 50-kHz vocalizations in rats. Physiol Behav 93:766–776
Wöhr M, Roullet FI, Hung AY, Sheng M, Crawley JN (2011) Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS ONE 6:e20631
Wright JM, Gourdon JC, Clarke PBS (2010) Identification of multiple call categories within the rich repertoire of adult rat 50-kHz ultrasonic vocalizations: effects of amphetamine and social context. Psychopharmacology (Berl) 211:1–13
Wright JM, Dobosiewicz MRS, Clarke PBS (2012) α- and β-Adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult rats. Neuropsychopharmacology 37:808–821
Wright JM, Dobosiewicz MR, Clarke PB (2013) The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations. Psychopharmacology (Berl) 225:853–868
Yildiz A, Guleryuz S, Ankerst DP, Ongur D, Renshaw PF (2008) Protein kinase C inhibition in the treatment of mania. A double blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry 65:255–263
Young JW, Minassian A, Paulus MP, Geyer MA, Perry W (2007) A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neurosci Biobehav Rev 31:882–896
Young JW, Henry BL, Geyer MA (2011) Predictive animal models of mania: hits, misses and future directions. Br J Pharmacol 164:1263–1284
Zarate CA Jr, Singh JB, Carlson FJ, Quiroz J, Jolkovsky L, Luckenbaugh DA et al (2007) Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord 9:561–570
Acknowledgements
This work was supported by the grant Schw 559/10-1 from the Deutsche Forschungsgemeinschaft. M. Pereira was funded by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Brazil). R. Andreatini received a researcher fellowship from CNPq. JC Brenes was funded by Deutscher Akademischer Austauschdienst (DAAD, Germany), and the University of Costa Rica.
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Pereira, M., Andreatini, R., Schwarting, R.K.W. et al. Amphetamine-induced appetitive 50-kHz calls in rats: a marker of affect in mania?. Psychopharmacology 231, 2567–2577 (2014). https://doi.org/10.1007/s00213-013-3413-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-013-3413-1